Active Pharmaceutical Intermediates

As Trump’s tariff announced on April 2, 2025, China will attract a higher tariff of 34 percent, against India with 26 percent. China is the biggest exporter of drugs and pharmaceutical intermediates to USA , followed by India at the 3rd rank in the exports. Besides tariff differences between the two nations, which will give an edge to India in exports, significance of India lies with different category of exports of drugs and pharmaceutical intermediates to USA. While India dominates in generic drugs exports to USA, China dominates in APIs (Active Pharmaceutical Intermediates) and finished drugs. In conclusion, Trump’s threat of high tariff is unlikely to be a major headwind to India’s growth. It is in a better position to address the tariff woes and navigate its growth, articulating its policy changes and accelerating political hobnobbing with USA. หนังใหม่2025